RGRobert M. Gifford

Robert M. Gifford

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Robert M. Gifford has a total of 110 co-authors. Here are the top co-authors by number of shared publications:

  • Natalie Taylor

    Academic Department of Military General Practice, Royal Centre for Defence Medicine, Birmingham, UK

    6 shared publications
  • David R. Woods

    Academic Department of Military Medicine, Research and Clinical Innovation Royal Centre of Defence Medicine Birmingham UK

    5 shared publications
  • D R Woods

    Academic Department of Military Medicine, Royal Centre for Defence Medicine, Birmingham, UK

    4 shared publications
  • Julie P. Greeves

    Army Headquarters

    4 shared publications
  • Rebecca M. Reynolds

    University/British Heart Foundation Centre for Cardiovascular Science, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom

    4 shared publications
  • Iain Thomas Parsons

    Academic Department of Military Medicine, Royal Centre for Defence Medicine, Birmingham, UK

    3 shared publications

Latest Publications

  • Open Access

    Physiological Basis of Sex Differences in Human Performance and Exercise‐Associated Pathology

    by David A. Holdsworth, Thomas J. O'LEary, Craig L. Doig, Natalie Taylor, Jasminder Dosanjh, David R. Woods, Michael J. Stacey, Robert M. Gifford

    The presence of sex differences in human physical performance is well‐established and shaped by distinct endocrine, anatomical and physiological mechanisms. Despite sustained advances, our understanding of how inherent biological factors drive variations in exercise capacity and related pathologies is still developing. This review examines data primarily from human trials on hormonal and other physiological determinants of sex differences in exercise performance. Higher testosterone in men leads to greater muscle mass, haemoglobin, bone size and cardiac output, explaining much of the performance gap between sexes. Female physiology confers advantages during prolonged submaximal exercise, including greater fat oxidation, lower carbohydrate dependence and improved fatigue resistance, which may help explain narrower gaps in ultra‐endurance events. These differences translate into a persistent performance gap (around 10%–15%) in most sports, particularly those requiring strength and power, although the gap narrows as event duration increases. Sex differences also influence responses to training and risk of exercise‐related pathology, including differences in stress responses, reproductive dysfunction (e.g., hypothalamic amenorrhoea), musculoskeletal injury and thermoregulation. These insights inform specific approaches in sports medicine and clinical endocrinology, emphasising the importance of sex as a fundamental biological variable in exercise physiology, sports performance and in clinical management of athletes and those in physically demanding jobs.


  • Open Access

    Robustness and value of data from the Oura Ring for personal monitoring in extreme environments with implications for clinical use: an observational study in an unassisted ski traverse of Antarctica

    by Natalie Taylor, Robert M Gifford, Michael Eager, Adrian J Wilson

    Objective: To evaluate the completeness and quality of Oura Ring data in a remote environment. Setting: The INSPIRE22 medical research expedition, a 950 km, 47-day unassisted trek from the Ronne Ice Shelf/land junction to the South Pole. Participants: Nine participants (six male) from either the UK military or civilians with experience of extreme environments and/or expedition medicine. Primary and secondary outcome measures: The primary outcome measures were missing data from the Ora Ring for movement measurement during six distinct activity periods within a day and heart rate (HR) during sleep. The secondary outcome measures were the agreement between movement measurement by the Oura Ring and a wrist-worn GENEActiv device for both an average day and the activity periods. Results: Overall, 3.2% of the minute-by-minute movement values were missing with a day-to-day variation of 0% to 83%. For the six activity periods, the median lowest incidence of missing values across participants was 4.44% (range 0–13.3%) during night-time and the highest 16.7% (range 6.67–60.0%) during sleep preparation. Agreement between the GENEActiv and Oura Ring measurements was activity-period dependent (r 2 =0.05–0.44). A Bland-Altman plot demonstrated a mean difference between the two devices for an average day of 0.41 (95% CI −0.45 to 1.27). For HR, the number of nights when data were available across participants ranged from 27 to 47. Within those nights, the median percentage of missing values across participants ranged from 5.99% to 18.2%. Conclusion: Research and healthcare relying on wearable technology should prioritise devices providing unprocessed data for robustness.

  • Improving real-world outcomes in contested environments with tranexamic acid autoinjectors

    by Robert M Gifford, Daniel Hawling, Emma Hivey, Charles Chacksfield, Lee Beales, Chris Wright

  • Bone calcium balance following an Antarctic expedition

    by Charlotte V. Coombs, Stefano Capella, Natalie Taylor, Robert M. Gifford, Anton Eisenhauer, Ana Kolevica, Alexander Heuser, Fiona Koivula, Julie P. Greeves, Thomas J. O'LEary

    This study provides new insight into bone calcium balance in extreme environments using a novel and noninvasive approach of naturally occurring calcium isotopes. Decreases in fat mass and body mass provide evidence that participants were in energy deficit, but most reproductive and thyroid hormones remained stable. Whole-body and regional aBMD decreased. Group-level urine δ 44/42 Ca-a marker of bone calcium balance did not change across the expedition, but individuals displayed significant variability in responses.


  • What makes wearable devices usable? Lessons learned from a 47-day Antarctic ski expedition to the South Pole (INSPIRE22)

    by Stefano Capella, Michael Eager, Fiona Koivula, Rob Gifford, Dean Cresswell, Natalie Taylor

    Wearable devices are used increasingly within the medical world, ranging from monitoring for head trauma to screening for heat injuries. Understanding what makes these devices tolerable to the end user in remote hostile environments is crucial for research, military, and humanitarian medicine, with broader translational implications. This opportunistic qualitative study trialled five different forms of wearable devices on the Interdisciplinary South Pole Innovation and Research Expedition 2022 (INSPIRE 22), an expedition which skied from the edge of the Antarctic land mass to the South Pole. It also examined the feasibility of near-real time analysis of wearable data from a hostile environment remotely from the UK. Key findings highlighted that usability of wearable devices was impacted by human-device interface factors (comfort, user buy in, and charging) and device resource requirements (power, data, and storage space on a personal mobile phone). Users required a more positive than negative aspects to maintain device interaction. Near-real-time data analysis of wearable technology from extreme environments is feasible but only on a small inconsistent scale due to limited connectivity. Reliable internet access, broader bandwidth, and better user access to data are essential to achieve meaningful health and performance insights for the individual and wider organisations.


  • GLP-1 receptor agonist use for obesity in service personnel

    by Nicola Jecks, C Hughes, N Macleod, R M Gifford

  • Open Access

    Preserved circadian variation in cortisol and androgens during a ski traverse of Antarctica in summer

    by Robert M. Gifford, Natalie Taylor, Jack Kendall, John Hattersley, Natalie Z. M. Homer, David R. Woods, Christopher Imray, Adrian J. Wilson

    Antarctic expeditions present extreme physiological challenges due to cold temperatures, high physical exertion, and 24-hour daylight. This observational study evaluated endocrine adaptation in nine participants (six men, three women) during a 47-day, 1,000 km unassisted ski traverse. Detailed salivary sampling was conducted before, during and after the expedition, corroborated by blood and hair sampling before and after the expedition. Cortisol, testosterone, and androstenedione were measured using mass spectrometry, and thyroid hormones via immunoassay. Diurnal cortisol, androstenedione and testosterone variation was preserved, while the morning cortisol increased during the expedition, suggesting that exercise demands overshadow the effects of continuous daylight in controlling hypothalamic-pituitary-adrenal and gonadal axis function. Morning testosterone decreased during the expedition, with a greater effect seen among men. No significant changes were seen in blood or hair steroid hormones. Gonadotropins in women indicated central suppression pre-expedition, normalizing post-expedition. Thyroid-stimulating hormone levels increased post-expedition without significant changes in free T3 or T4, consistent with mild polar T3 syndrome. These findings highlight the adaptability of hypothalamic-pituitary function to combined stressors of exercise, energy deficit, and cold. This is the first study to capture in situ endocrine responses during an Antarctic traverse, advancing our understanding of human adaptation in extreme environments.


  • Influence of military preventive policy for recruit training on COVID-19 seroconversion: the IMPACT-COVID-19 study

    by Michael John Stacey, P Ferentinos, F Koivula, I T Parsons, R M Gifford, D Snape, A Nicholson-Little, S Faustini, N P Walsh, L E Lamb, et al.

    Introduction Recruitment and training is vital to maintaining the size, deployability and effectiveness of armed forces, but was threatened early in the COVID-19 pandemic. Reports suggested asymptomatic seroconversion driving SARS-CoV-2 transmission in young adults. Potential association between lower vitamin D status and increased infection risk was also highlighted. We aimed to prospectively determine seroconversion and test the hypothesis that this would vary with vitamin D supplementation in representative populations. Methods Two cohorts were recruited from Yorkshire, Northern England. Infantry recruits received daily oral vitamin D (1000 IU for 4 weeks, followed by 400 IU for the remaining 22 weeks of training) in institutional countermeasures to facilitate ongoing training/co-habitation. Controls were recruited from an un-supplemented University population, subject to social distancing and household restrictions. Venous blood samples (baseline and week 16) were assayed for vitamin D and anti-SARS-CoV-2 spike glycoprotein antibodies, with additional serology (weeks 4, 9, 12) by dried blood spot. The impact of supplementation was analysed on an intention-to-treat basis in volunteers completing testing at all time points and remaining unvaccinated against SARS-CoV-2. Variation in seroconversion with vitamin D change was explored across, and modelled within, each population. Results In the military (n=333) and University (n=222) cohorts, seroconversion rates were 44.4% vs 25.7% (p=0.003). At week 16, military recruits showed higher vitamin D (60.5±19.5 mmol/L vs 53.5±22.4 mmol/L, pConclusion Among unvaccinated populations, SARS-CoV-2 infection of infantry recruits was not reduced by institutional countermeasures, versus civilians subject to national restrictions. Vitamin D supplementation improved serum levels, but the implementation did not have a clinically meaningful impact on seroconversion during military training.